Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors

DURHAM, N.C. & SEATTLE--(BUSINESS WIRE)--Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors. Dr. McHutchison joins as...

Click to view original post